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Abstract
RNA viruses induce specialized membranous structures for use in genome replication.
These structures are often referred to as replication organelles (ROs). ROs exhibit distinct
lipid composition relative to other cellular membranes. In many picornaviruses, phosphatidy-
linositol-4-phosphate (PI4P) is a marker of the RO. Studies to date indicate that the viral 3A
protein hijacks a PI4 kinase to induce PI4P by a mechanism unrelated to the cellular path-
way, which requires Golgi-specific brefeldin A-resistance guanine nucleotide exchange fac-
tor 1, GBF1, and ADP ribosylation factor 1, Arf1. Here we show that a picornaviral 3CD
protein is sufficient to induce synthesis of not only PI4P but also phosphatidylinositol-4,5-
bisphosphate (PIP2) and phosphatidylcholine (PC). Synthesis of PI4P requires GBF1 and
Arf1. We identified 3CD derivatives: 3CDm and 3CmD, that we used to show that distinct
domains of 3CD function upstream of GBF1 and downstream of Arf1 activation. These
same 3CD derivatives still supported induction of PIP2 and PC, suggesting that pathways
and corresponding mechanisms used to induce these phospholipids are distinct. Phospho-
lipid induction by 3CD is localized to the perinuclear region of the cell, the outcome of which
is the proliferation of membranes in this area of the cell. We conclude that a single viral pro-
tein can serve as a master regulator of cellular phospholipid and membrane biogenesis,
likely by commandeering normal cellular pathways.
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Author summary
Picornaviruses replicate their genomes in association with host membranes. Early during
infection, existing membranes are used but remodeled to contain a repertoire of lipids
best suited for virus multiplication. Later, new membrane synthesis occurs, which requires
biosynthesis of phosphatidylcholine in addition to the other more specialized lipids. We
have learned that a single picornaviral protein is able to induce membrane biogenesis and
decorate these membranes with some of the specialized lipids induced by the virus. A
detailed mechanism of induction has been elucidated for one of these lipids. The ability of
a single viral protein to commandeer host pathways that lead to membrane biogenesis was
unexpected. This discovery reveals a new target for antiviral therapy with the potential to
completely derail all aspects of the viral lifecycle requiring membrane biogenesis.
Introduction
Myriad cellular mechanisms exist to thwart viral infection [1–4]. These mechanisms are trig-
gered when a cellular pattern recognition receptor (PRR) engages a virus-associated molecular
pattern, for example 5’-triphosphorylated RNA, the absence of 2’-O-methylation of the mRNA
cap, double-stranded RNA, among many others [1–4]. PRRs are located at every portal of viral
entry into a cell but are particularly abundant in the cytoplasm, the site of replication of most
RNA viruses, especially positive-strand RNA viruses. RNA viruses have evolved multiple
mechanisms to escape host innate immunity [1–4]. Some mechanisms are specific, for exam-
ple the use of virus-encoded protein(s) to bind and/or to degrade a PRR [1–4]. One generic
approach exploited by positive-strand RNA viruses may be the use of a replication organelle for
genome replication, which limits surveillance by cellular antiviral defenses [5], although the
need to evade host defenses in cell culture may not be absolute [6].
Virus-induced replication organelles, also referred to as replication complexes, are apparent
in cells infected by positive-strand RNA viruses within a few hours post-infection [7,8]. Some
viruses remodel existing membranes. For example, Flaviviruses (Dengue virus, West Nile virus
and Zika virus) induce invaginations of negative curvature in membranes of the endoplasmic
reticulum (ER) that appear as vesicle packets or spherules [9]. Alphaviruses (Sindbis virus and
chikungunya virus) induce similar structures but use membranes of endosomes or the lyso-
some instead [10]. In contrast, hepacivirus (hepatitis C virus, HCV) and picornaviruses (polio-
virus, PV; Coxsackievirus B3, CVB3; human rhinovirus HRV; and foot-and-mouth disease
virus, FMDV) use organellar or vesicular membranes to induce protrusions of positive curva-
ture that interact to form a distinct, virus-induced entity [11–14].
The creation of sites for genome replication that are only permeable to small molecules cre-
ates a dilemma for trafficking of viral proteins to these sites, given the expectation that viral
proteins are produced in the cytoplasm. Therefore, production and/or trafficking of viral pro-
teins and formation of the replication organelle need to be coordinated. For years, it was pre-
sumed that a combination of interactions between viral proteins and between viral and host
proteins would be essential to this coordination [15]. However, it became clear several years
ago that the phosphoinositide, phosphatidylinositol-4-phoshate (PI4P), is enriched in the
picornavirus and hepacivirus replication organelles [16]. This discovery inspired the hypothe-
sis that PI4P contributes to recruitment of viral and cellular proteins to the replication organ-
elle [16].
Phosphoinositides have a well-established role in cellular protein trafficking and in cou-
pling activation of protein function to phosphoinositide binding [17]. The RNA-dependent
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RNA polymerases (RdRps) from PV and CVB3 have been reported to bind to PI4P, consistent
with this role during infection [16]. PI4P is enriched in the Golgi apparatus (Golgi) [18]. A
phosphatidylinositol (PI)-4 kinase (PI4K) produces PI4P from PI. At the Golgi, the type IIIβ
and type IIα PI4Ks are used [18]. PI4KIIIβ (referred to herein by its gene name, PI4KB) is acti-
vated by a pathway in which the guanine-nucleotide exchange factor (GEF), Golgi-specific bre-
feldin A-resistance GEF (GBF1), is recruited to Golgi membrane by an ill-defined mechanism
and converts the GDP-bound form of ADP-ribosylation factor 1 (Arf1) to its active GTP-
bound form [19]. Arf1 activation is a requirement for activation of PI4KB; however, the steps
between Arf1 and PI4KB activation are not clear [19]. Further complicating our understanding
of steps succeeding Arf1 activation is the fact that numerous Golgi functions are controlled by
effectors whose recruitment to membranes also rely on Arf1 activation using ostensibly differ-
ent and incompletely elaborated mechanisms [20,21].
The mechanism(s) used by viruses to induce PI4P remains a topic of active research. There
is good evidence for picornaviruses and hepaciviruses that either PI4KB or PI4KIIIα (referred
to herein by its gene name, PI4KA) can be used [22]. In addition, studies of infected cells have
implicated GBF1 and Arf1 as contributors to PI4P induction [16,23]. The most detailed mech-
anistic studies have been performed using PV and CVB3. The earliest studies concluded that
the picornaviral 3A protein recruits PI4KB to membranes [16,24,25]. However, more recent
studies have suggested that PI4KB recruitment to membranes by 3A uses a mechanism inde-
pendent of GBF1 and Arf1 [26–29]. These observations have been interpreted to mean that
picornaviruses have evolved a mechanism to recruit PI4 kinases to membranes for production
of PI4P that is unique relative to that used by the cell.
Here we show that ectopic expression of a single picornaviral protein, the 3CD protein, is
sufficient to induce PI4P in cells. PI4P induction appears to reflect the capacity of 3CD to
hijack and constitutively activate the normal PI4P biogenesis pathway of the Golgi. GBF1,
Arf1-GTP and activated PI4KB are required for PI4P induction. Amino acid substitutions in
the 3D domain of 3CD (3CDm) interfere with steps pre-Arf1 activation; those in the 3C
domain of 3CD (3CmD) interfere with steps post-Arf1 activation. Co-expression of 3CDm and
3CmD restore PI4P induction, consistent with 3CD functioning in two discrete steps. The
steps targeted by 3CD appear to be those understood least in the cellular pathway. Interest-
ingly, 3CD binds to PI4P-containing membranes but not to membranes containing only phos-
phatidylcholine (PC). Both 3CD derivatives retain the capacity to bind to PI4P-containing
membranes. In addition to PI4P, expression of 3CD also induces phosphatidylinositol-
4,5-bisphosphate (PIP2) and PC in cells. Neither 3CDm nor 3CmD prevented induction of
PIP2 or PC, suggesting distinct mechanisms for induction of these phospholipids relative to
PI4P. Lipid induction by 3CD leads to a substantial proliferation of membranes in the perinuc-
lear region of the cell. In summary, we have discovered that a single viral protein is sufficient
to commandeer multiple phospholipid biosynthetic pathways and create new membranes for
use by the virus in the genesis of its replication organelle. Elucidation of the mechanisms used
by 3CD to induce membrane biogenesis may reveal non-genomic mechanisms used by the cell
to regulate this process.
Results
Expression of 3CD protein in HeLa cells induces PI4P synthesis
Although it is now quite clear that phosphoinositides are exploited by many RNA viruses and
mark the sites of genome replication, the viral factor(s) contributing to synthesis of these lipids
and corresponding mechanisms are largely unknown. The PV genome encodes a polyprotein
that can be divided into structural (P1 in Fig 1A) and non-structural (P2 and P3 in Fig 1A)
regions. The P3 region is processed by the protease activity residing in the 3C domain to yield
3AB and 3CD protein as the primary cleavage products (Fig 1A). Several years ago, we
reported a PV mutant (GG PV) that expresses 3ABC and 3D as the primary cleavage products
Fig 1. Ectopic expression of poliovirus 3CD causes induction and redistribution of PI4P. (A) Schematic representation of the major pathway
for processing of the P3 polyprotein. 3C-encoded protease activity cleaves at the Gln-Gly junction between the 3B and 3C proteins to produce 3AB
and 3CD proteins. (B) Effect of 3AB, 3CD, 3CDpro+, and 3A expression on PI4P levels and localization in HeLa cells. Cells were transfected with
in-vitro synthesized mRNA for EGFP, 3AB, 3CD, 3CDpro+, or 3A. Four hours post-transfection, cells were immunostained for the presence of
PI4P (red) and the expressed protein (green). The nucleus was stained with DAPI (blue). Mock represents cells that were taken through the
transfection protocol in the absence of mRNA. (C) Quantification of PI4P intensity. The PI4P fluorescence intensity was determined using 11 z-
stacks per transfected cell (n = 30). The average PI4P intensity of mock-transfected cells was used to normalize the value measured in each cell, the
results of which are plotted in the graph. The averages of the normalized values were: 1.00 ± 0.03 (SEM) in mock-transfected cells, 0.81 ± 0.04
(SEM) in 3AB transfected cells, 4.98 ± 0.43 (SEM) in 3CD-transfected cells, and 0.53 ± 0.03 (SEM) in 3A transfected cells. The difference was
significant on all comparisons, based on a Student’s t-test, which gave a P value of<0.0001. (D) Effect of 3AB, 3CD, and 3A expression on Golgi
integrity. HeLa cells were transfected as above and immunostained for Giantin (green) and PI4P (red) 4 h post-transfection.
https://doi.org/10.1371/journal.ppat.1007086.g001
[30]. This mutant exhibits a delay in the events that lead up to genome replication, as well as a
delayed induction of PI4P biosynthesis [30,31]. This observation implicated 3AB and/or 3CD
in the PI4P-induction process.
Expression of PV proteins by DNA transfection was problematic, so we used transcription
in vitro to produce RNA that we capped and polyadenylated in vitro to produce mRNAs for
3AB, 3CD, and enhanced green fluorescent protein (EGFP), which served as a negative con-
trol. The protease activity of 3CD was inactivated by changing the codon for the catalytic Cys
residue to one coding for Gly. We transfected these mRNAs into HeLa cells and used immu-
nofluorescence (IF) to monitor protein expression and the fate of PI4P 4 h post-transfection.
EGFP expression caused no change in PI4P levels or localization relative to mock-transfected
cells (compare EGFP to mock in Fig 1B). 3AB expression caused both a loss of PI4P localiza-
tion at the Golgi and a reduction in the level of PI4P detected (3AB in Fig 1B and 1C). 3CD
expression caused an increase in PI4P levels, as well as PI4P redistribution (3CD in Fig 1B and
1C). PI4P levels increased by an average of five fold (Fig 1C). For completeness, we also evalu-
ated 3A and 3CD with an active protease (3CDpro+). Like 3AB, 3A expression caused a loss of
PI4P localization at the Golgi (3A in Fig 1B). 3A caused a greater reduction in PI4P detected
than 3AB (compare 3A to 3AB in Fig 1C). The addition of protease activity to 3CD caused no
discernible difference to induction or redistribution of PI4P (3CDpro+ in Fig 1B).
PI4P is present at the highest level in the Golgi [18]. PV infection causes Golgi dissolution
[32]. One mechanism of Golgi loss is inhibition of GBF1 by 3A protein which interferes with
replenishment of Golgi membranes by blocking anterograde transport from ERGIC
[24,33,34]. In order to determine if the observed changes to PI4P levels was a consequence of
perturbed Golgi integrity, we repeated the experiment described above. We stained cells with
an antibody to PI4P to show changes to PI4P and one to Giantin to image the Golgi. Expres-
sion of neither 3AB nor 3CD impacted Golgi organization (Giantin in Fig 1D). Expression of
3A, however, caused apparent dissolution of the Golgi as previously reported [24,35].
Induction of PI4P by 3CD occurs by a non-genomic mechanism and
requires GBF1 and PI4KB
The 3CD protein was clearly localized primarily to the cytoplasm (Fig 1B); however, it is known
that 3CD can enter the nucleus and alter gene expression [36]. Perturbations to gene expression
are thought to require 3C-protease activity, which was inactivated for the purpose of this study.
Nevertheless, to formally rule out the possibility that 3CD expression perturbs transcription to
induce PI4P, we transfected 3CD mRNA into cells treated with actinomycin D (AMD). AMD
interferes with transcription by all three cellular RNA polymerases [37]. Disruption of RNA
polymerase I by AMD causes redistribution of Nucleolin in the nucleus [38]; we used this phe-
nomenon as a positive control for AMD treatment (compare anti-Nucleolin -/+ AMD in Fig
2A). The presence of AMD did not interfere with 3CD-mediated induction of PI4P (Fig 2B).
In order to determine if 3CD-mediated induction of PI4P used aspects of the normal path-
way for PI4P production at the Golgi, we measured the impact of brefeldin A (BFA), golgicide
A (GCA) and PIK93 on PI4P induction. BFA targets at least three cellular GEFs including
GBF1 [39]. GCA only inhibits GBF1 [39]. PIK93 inhibits PI4KB [40]. 3CD was unable to
induce PI4P in the presence of BFA (Fig 2C) or GCA (Fig 2D). The presence of PIK93 reduced
the extent to which 3CD was able to induce PI4P (Fig 2E) by more than two fold (Fig 2F).
Expression of 3CD leads to Arf1 activation
The preceding experiment suggests that 3CD hijacks the normal cellular pathway, which
includes Arf1 activation by converting Arf1-GDP to Arf1-GTP. In order to measure
intracellular levels of Arf1-GTP, we used a GGA3 (Golgi associated, gamma-adaptin ear con-
taining, Arf-binding protein 3) pull-down assay (Fig 3A) [41]. GGA3 is a clathrin adaptor pro-
tein that selectively binds to Arf-GTP [41]. We validated the assay using PV-infected cells.
Infection caused an increase of Arf1-GTP (S1A Fig) of seven fold (S1B Fig). Expression of
3CD alone caused an increase in Arf1-GTP (Fig 3B) of four fold (Fig 3C).
Fig 2. 3CD-mediated induction of PI4P does not require host transcription but uses GBF1 and a type III PI4
kinase(s). (A) Effect of actinomycin D (AMD) on nucleolin localization. HeLa cells were treated with AMD (5 μg/mL)
for 4 h then immunostained for nucleolin (red) [37]. (B) Effect of actinomycin D (AMD) on 3CD-mediated induction
of PI4P. HeLa cells were maintained in the absence or presence of AMD (5 μg/mL) prior to transfection with 3CD
mRNA. Cells were immunostained for PI4P (red) or 3CD (green); the nucleus was stained with DAPI (blue).
Subsequent experiments were performed as described for AMD but used the following inhibitors: (C) brefeldin A
(BFA, 2 μg/mL), (D) golgicide A (GCA, 10 μM), and (E) PIK93 (15 μM). All of these treatments interfered with
induction of PI4P. PIK93 was the least effective. (F) Quantification of the PI4P levels per cell in the absence (1.8 ± 0.1 x
108) and presence (7.1 ± 0.5 x 107) of PIK93. Error bars represent SEM; Student’s t-test gave a P value of<0.0001.
https://doi.org/10.1371/journal.ppat.1007086.g002
Redistribution of Arf1, GBF1, and PI4KB caused by 3CD expression or PV
infection without apparent changes to integrity of Golgi or ER
The biochemical and pharmacological studies point to the hijacking of Arf1, GBF1, and PI4KB
for induction of PI4P biosynthesis. All three of these proteins are present in abundance at the
Golgi (anti-Arf1, anti-GBF1, and anti-PI4KB in column marked Mock in Fig 4A and 4B).
Expression of 3CD caused redistribution of all three of these proteins (anti-Arf1, anti-GBF1,
and anti-PI4KB in column marked 3CD in Fig 4A and 4B). Arf1 and GBF1 now appeared as
Fig 3. Ectopic expression of 3CD causes activation of Arf1. (A) Schematic of assay used to detect GTP-bound
(activated) Arf1. HeLa cells were transfected with or without 3CD mRNA. A lysate was prepared using transfected cells
and combined with magnetic beads to which the GGA3 adaptor protein was immobilized. Arf1-GTP is uniquely
bound by the GGA3 adaptor protein [41]. Beads were isolated, washed, and boiled in SDS-PAGE sample buffer to elute
proteins. Eluted proteins were resolved by SDS-PAGE and detected by Western blotting using an anti-Arf1 antibody.
(B) Detection of Arf1-GTP (bead-eluted material), total Arf1 (from unfractionated lysate), and 3CD (from
unfractionated lysate) by Western blot using the indicated antibodies and enhanced chemifluorescence. (C) The
magnitude of Arf1 activation was determined by quantifying the fluorescence intensity of Arf1-GTP and total Arf1 and
reporting the quotient thereof. The averages of the values for the quotients (n = 3) were: 0.43 ± 0.03 (SEM) in EGFP-
transfected cells and 1.77 ± 0.03 (SEM) in 3CD-transfected cells. The difference was significant based on a Student’s t-
test, which gave a P value of<0.0001.
https://doi.org/10.1371/journal.ppat.1007086.g003
speckles in the perinuclear region of the cell (anti-Arf1 and anti-GBF1 in column marked 3CD
in Fig 4A and 4B). PI4KB was more diffusely distributed throughout the cytoplasm (anti-
PI4KB in column marked 3CD in Fig 4A and 4B) in a pattern that closely resembled that of
3CD (merge in column marked 3CD in Fig 4A). In no case did the co-localization of Arf1,
GBF1, or PI4KB with PI4P appear as strong in the presence of 3CD as observed in its absence
(Fig 4B). Importantly, redistribution of Arf1, GBF1, and PI4KB was not caused by changes to
Golgi integrity (anti-Giantin in Fig 4C) or ER integrity (anti-Calnexin in Fig 4C).
We compared the changes to Arf1, GBF1, and PI4KB localization caused by 3CD to
corresponding changes caused by infection. Here we took advantage of our observation
that infection in the presence of the replication inhibitor, guanidine hydrochloride
(GuHCl), is sufficient to induce to PI4P and membrane biogenesis [42]. Because viral pro-
teins do not accumulate to a detectable level by the indirect immunofluorescence assay in
the presence of GuHCl (anti-3D in column marked PV in Fig 5A), we used relocalization
of PI4P to distinguish uninfected cells from infected cells (compare anti-PI4P in column
marked Mock to column marked PV in Fig 5A and 5B). As observed for 3CD expression,
PV infection caused redistribution of Arf1, GBF1, and PI4KB (anti-Arf1, anti-GBF1, and
anti-PI4KB in column marked PV in Fig 5A) without an impact on integrity of the Golgi
(anti-Giantin in column marked PV in Fig 5B) or ER (anti-Calnexin in column marked
PV in Fig 5B). For completeness, we repeated this experiment in the absence of GuHCl
(S2 Fig). These experiments reinforced the observations made above in the presence of
GuHCl.
Identification of genetic determinants of 3CD required for PI4P induction
For years, our laboratory has been interrogating the structure, function and dynamics of PV
3C and 3D proteins, creating a large bank of recombinant PVs with mutations in the corre-
sponding genes. We screened this collection to identify 3CD genes that failed to induce PI4P
and identified several. Changing both Leu-630 and Arg-639 in the 3D domain to Asp (referred
to throughout as 3CDm) interfered with PI4P induction (Fig 6A and 6B). Changing Lys-12 in
the 3C domain to Leu (referred to throughout as 3CmD) also interfered with PI4P induction
(Fig 6A and 6B). If each domain functions independently, for example at distinct steps of the
PI4P-induction pathway, then each may complement the other. To test this possibility, we co-
expressed 3CDm and 3CmD. PI4P induction was restored (Fig 6A and 6B).
The pathway for PI4P induction is bisected at the Arf1-activation step. Therefore, we used
the GGA3 pull-down assay to determine where in the process of PI4P induction each 3CD
derivative was impaired. 3CDm failed to activate Arf1, suggesting a defect at a step preceding
Arf1 activation (Fig 6C and 6D). In contrast, 3CmD activated Arf1, consistent with a defect at
a step succeeding Arf1 activation (Fig 6C and 6D).
Introduction of 3CDm and 3CmD into a PV subgenomic replicon that expresses firefly lucif-
erase completely abolishes genome replication as measured by luciferase activity (Fig 6E). If
the observed replication defect is related to functions of 3CD required for formation of the
RO, then we should be able to rescue this defect by providing a wild-type copy of 3CD in trans.
However, if the defect is related to other genome-replication functions of 3CD, then we should
be unable to rescue [43,44]. We delivered the “wild-type” 3CD in the form of a mutant in
which the catalytic site of the RdRp has been inactivated by changing the signature GDD
sequence to GAA. As expected, the GAA replicon was dead (Fig 6E). Co-transfection of the
replicons expressing 3CDm or 3CmD and GAA showed complementation of only 3CmD,
although both the kinetics and yield of luciferase activity were reduced relative to the bona fide
wild-type replicon (Fig 6E).
Fig 4. 3CD expression causes redistribution of Arf1, GBF1, and PI4KB to sites of PI4P synthesis without affecting Golgi or ER
integrity. (A) HeLa cells expressing 3CD were immunostained for the presence of the following: (i) Arf1, (ii) GBF1, or (iii) PI4KB (green).
The inability of GAA to complement 3CDm was anticipated because the amino acid substi-
tutions in the 3D domain of 3CDm interferes with recruitment of the polymerase to the site of
genome replication [45]. The combination therefore should be unable to perform genome rep-
lication. Co-transfection of 3CDm and 3CmD should not have this problem. Each of these two
3CD expression was monitored (red); the nucleus is stained witth DAPI (blue). (B) The same experiment as performed in panel A, with
immunostaining for PI4P (red) instead of 3CD. (C) HeLa cells expressing 3CD were immunostained for the presence of the following: (i)
Giantin or (ii) Calnexin (green). 3CD expression was monitored (red); the nucleus is stained witth DAPI (blue).
https://doi.org/10.1371/journal.ppat.1007086.g004
Fig 5. Changes to Arf1, GBF1, and PI4KB caused by 3CD are also observed during PV infection in the absence of replication. (A) HeLa cells were infected with PV
at an MOI of 10 in the presence of 3 mM GuHCl, a replication inhibitor. Four hours post-infection, cells were immunostained for the following: (i) PI4P (red) (ii) Arf1
(green), (iii) GBF1 (green), or (iv) PI4KB (green). Under these conditions, PV proteins are expressed at a level below our limit of detection. Infected cells can be
identified by changes to pattern of PI4P expression (red). The nucleus was stained with DAPI (blue). (B) HeLa cells were infected with PV at an MOI of 10 in the
presence of 3 mM GuHCl. Four hours post-infection, cells were immunostained for the following: (i) Giantin or (ii) Calnexin (green). PI4P is labeled red; DAPI is
shown in blue.
https://doi.org/10.1371/journal.ppat.1007086.g005
Fig 6. Identification of 3CD variants with substitutions in 3C or 3D domain that impair induction of PI4P biosynthesis at distinct steps. (A) 3CD
derivatives with amino acid substitutions in 3C (3CmD) or 3D (3CDm) were expressed individually or together in HeLa cells and immunostained for PI4P
(red) and 3CD (green). The nucleus was stained with DAPI (blue). (B) Quantification of PI4P intensity per cell was performed as described in the legend
to Fig 1C. The averages of the normalized values were: 1.00 ± 0.04 (SEM) in mock-transfected cells; 1.06 ± 0.04 (SEM) in 3CDm-transfected cells;
1.10 ± 0.04 (SEM) in 3CmD-transfected cells; and 3.08 ± 0.13 (SEM) in 3CDm and 3CmD co-transfected cells. The level of PI4P induction observed in co-
transfected cells was significant when compared to any other experiment based on a Student’s t-test, which gave a P value of<0.0001. (C) Activation of
Arf1 by the 3CD derivatives was determined as described in the legend to Fig 3A. (D) The magnitude of Arf1 activation was determined as described in
the legend to Fig 3B. The averages of the values for the quotients (n = 3) were: 0.43 ± 0.02 (SEM) in mock-transfected cells; 0.37 ± 0.07 (SEM) in 3CDm-
transfected cells; 1.27 ± 0.09 (SEM) in 3CmD-transfected cells. For mock vs 3CDm, mock vs 3CmD and 3CDm vs 3CmD, a Student’s t-test yielded P values
defective replicons complemented the other (Fig 6E and 6F), consistent with defects to induc-
tion of PI4P biosynthesis contributing to the inability of these replicons to replicate.
While we only identified one 3CDm variant that incapacitated PI4P production, we identi-
fied two additional 3CmD variants incapable of PI4P induction (S3A and S3B Fig). These
3CmD variants changed Arg-13 to Leu (referred to as R13L) or Arg-84 to Leu (referred to as
R84L). Both variants were capable of Arf1 activation (S3C and S3D Fig) and could be comple-
mented to varying degrees by the GAA replicon (S3E Fig). The efficiency with which replica-
tion was restored by the GAA replicon could be ordered as follows: R13L> K12L> R84L.
3CD overcomes PI4P-depletion activity of 3AB but not that of 3A
Expression of both 3AB and 3A diminished the abundance of PI4P in cells (Fig 1C). The
mechanisms used by 3AB and 3A to interfere with PI4P levels may be distinct, given the inabil-
ity of 3AB (column 3AB in Fig 1D) to interfere with Golgi integrity but the ability of 3A to do
so (column 3A in Fig 1D). Regardless of the mechanism, however, the capacity for 3CD to
overcome this inhibition is paramount to the mechanism of 3CD activation of PI4P biosynthe-
sis being relevant to the mechanism of PV activation of PI4P biosynthesis. Cells co-expressing
3CD and 3AB produced as much PI4P as cells expressing 3CD alone (compare 3CD to 3CD
+3AB in Fig 7A and 7B). In stark contrast, cells co-expressing 3CD and 3A failed to support
of 0.4498, 0.0007 and 0.0012, respectively. (E) Complementation of 3CDm- or 3CmD-expressing subgenomic replicons. HeLa cells were transfected with
replicon RNA indicated in the key. GAA refers to a replicon expressing a catalytically inactive 3D-encoded polymerase; the corresponding 3CD-GAA
should function normally in PI4P induction. Luciferase activity was measured every hour post-transfection as indicated. This experiment was performed
twice. Trial one was performed in triplicate; trial two was performed in duplicate. The mean of the values obtained in trial two are shown. (F) 3CmD or
3CDm expressing subgenomic replicons were expressed individually or together in HeLa cells and immunostained for the presence of PI4P (red) and 3CD
(green). The nucleus was stained with DAPI (blue).
https://doi.org/10.1371/journal.ppat.1007086.g006
Fig 7. Inhibitory activity of 3AB on PI4P biosynthesis can be overcome by 3CD but that of 3A cannot. (A) HeLa cells expressing 3CD in the absence or
presence of 3AB or 3A were immunostained for the presence of PI4P (red), 3CD (green), and 3A(B) (magenta). The nucleus is stained with DAPI (blue). (B)
Quantification of PI4P intensity per cell was performed as described in the legend to Fig 1C. The averages of the normalized values were: 1.00 ± 0.03, n = 40
(SEM) in mock cells; 2.61 ± 0.13, n = 30 (SEM) in 3CD-transfected cells; 2.37 ± 0.10, n = 30 (SEM) in 3CD and 3AB co-transfected cells; and 0.83 ± 0.03, n = 35
(SEM) in 3CD and 3A co-transfected cells. The level of PI4P induction observed in 3CD and 3AB co-transfected cells was significant when compared to mock
or 3CD and 3A co-transfected cells based on a Student’s t-test, which gave a P value of<0.0001 in both instances. There was no significant difference between
3CD-transfected cells and 3AB and 3CD co-transfected cells based on a Student’s t-test, which gave a P value of 0.1490. The diminished level of PI4P observed in
3CD and 3A co-transfected cells was significant when compared to mock based on a Student’s t-test, which gave a P value of<0.0001.
https://doi.org/10.1371/journal.ppat.1007086.g007
induction of PI4P biosynthesis (compare 3CD to 3CD+3A in Fig 7A and 7B). Together, these
observations suggest unexpected functional differences between 3AB and 3A that give rise to
different outcomes for PI4P biosynthesis. The ability of 3CD to overcome the action of 3AB to
induce PI4P biosynthesis is consistent with the scenario in the infected cell, because 3AB is the
predominant species [46].
3CD binds to PI4P-containing membranes
Recently, we developed an assay to study the interaction of phosphoinositide-binding proteins
with membranes using a supported-lipid bilayer prepared in the channels of a microfluidic
device [47]. A fluorescence probe in the bilayer senses protein binding, causing fluorescence
quenching for the proteins used to date. The system was validated using the Pleckstrin homol-
ogy (PH) domain from phospholipase C δ1 that binds to PIP2 [47] and has now been validated
for use with PI4P as well [48].
The first study demonstrating PI4P induction showed that the 3D domain alone was able to
bind to immobilized PI4P [16]. It therefore seemed reasonable to expect that 3CD would also bind
to PI4P. To test this possibility formally, we used the chip-based assay to evaluate 3CD binding to
PC-based membranes in the absence or presence of PI4P. 3CD bound to the membrane only
when PI4P was present (Fig 8). Interestingly, both 3CDm and 3CmD retained the capacity to bind
to PI4P-containing membranes, suggesting that the ability to be recruited to the appropriate mem-
branes remained intact. A statistically significant difference in the binding affinity for both deriva-
tives relative to wild-type 3CD was noted (Fig 8). 3CmD exhibited two-fold higher affinity binding;
3CDm exhibited two-fold lower affinity binding (Fig 8B and 8C). If and how these changes to
PI4P-binding affinity correlate to the observed phenotype in cells requires further investigation.
Expression of 3CD in HeLa cells induces synthesis of PIP2 and PC
Given the completely unexpected capacity of 3CD alone to induce production of PI4P, we
decided to evaluate the fate of other phospholipids in PV-infected cells and determine the
Fig 8. 3CD derivatives exhibit modulated binding to PI4P-containing membranes. A microfluidics-based, membrane-binding assay was used to measure
membrane binding by 3CD and derivatives thereof [47]. A bilayer is formed in the channels of the microfluidics device. The bilayer contains a
phosphatidylcholine (POPC) and a fluorescent derivative of phosphatidylethanolamine (0.5 mol%) in the presence or absence of PI4P (7.5 mol%). Binding of the
protein to the membrane quenches fluorescence, which enables measurement of the dissociation constant, Kd,app. (A) Image of the fluorescence observed in the
channels of the device as a function of 3CD concentration using a 10X objective. (B) The change in fluorescence was converted to percent of bilayer saturated (see
Materials and Methods) and plotted as a function of protein concentration. Data were fit to a Langmuir binding isotherm with an n = 1 to obtain values for Kd,app.
Three independent experiments were performed. Error bars represent standard error of the mean. (C) Values for Kd,app measured for 3CD and its derivatives on
the indicated bilayer. When using a bilayer consisting of POPC and the fluorescence probe, no change in fluorescence was observed at a concentration as high as
5000 nM.
https://doi.org/10.1371/journal.ppat.1007086.g008
extent to which 3CD contributes to their production. Immunological reagents are commer-
cially available for the following phosphoinositides: PI3P, PI3,4P2, PI3,5P2 and PI4,5P2
(PIP2). In addition to PI4P, PV infection also induces production of PC [49,50]. We therefore
evaluated synthesis of PC here as well. Of the four additional phosphoinositides tested, PIP2
showed the most robust, reproducible difference in PV-infected cells relative to mock-infected
cells (Fig 9A). We observed a near 7-fold increase in PIP2 (Fig 9A). In the uninfected cell,
PIP2 localized predominantly to the plasma membrane. This staining can only be observed at
0˚C [51]. We used staining of the plasma membrane to validate the specificity of our anti-PIP2
antibody (S4 Fig). As previously reported, PV infection elevated PC levels by 3-fold relative to
control (Fig 9B).
We evaluated PIP2 and PC levels in 3CD-transfected cells. We observed a 5-fold increase in
PIP2 (panel 3CD in Fig 9C) and a 2-fold increase in PC (panel 3CD in Fig 9C) in the presence
of 3CD. Like induction of PI4P, 3CD-mediated induction of PIP2 and PC occur by post-tran-
scriptional mechanisms as AMD did not impact levels of these phospholipids (S5A and S5B
Fig, respectively). Next, we determined if the genetic requirements for PIP2 and PC induction
were the same as those for PI4P. 3CDm caused a small but statistically significant (P <0.0001)
1.7-fold decrease in PIP2 levels relative to that observed for wild-type 3CD (compare 3CDm to
3CD in Fig 9C). None of the 3CmD variants caused a difference in PIP2 levels relative to wild-
type 3CD (Figs 9C and S5C). Neither the 3CDm nor the 3CmD variants impacted the outcome
of 3CD-mediated induction of PC (Figs 9D and S5D).
Expression of 3CD in HeLa cells induces membrane proliferation
Induction of so many different phospholipids by 3CD begs the question: where do they all go?
To address this question, we transfected cells with EGFP mRNA as a negative control or 3CD
mRNA and compared the ultrastructure of the cell as observed by standard transmission elec-
tron microscopy. We observed a normal ultrastructure in EGFP-transfected cells (panel EGFP
in Fig 10). The Golgi was easily identifiable in the perinuclear region and unremarkable
(enlargement of panel EGFP in Fig 10). In contrast, we observed hypertrophy of membranes
in the perinuclear region of 3CD transfected cells (panel 3CD in Fig 10), so much so that the
Golgi stacks were no longer distinguishable from the layers of 3CD-induced membranes
(enlargement of panel 3CD in Fig 10). Clearly, Golgi was present and intact based on Giantin
staining (Fig 1D). The ability of 3CDm and 3CmD to induce PC (Fig 9D) suggests that these
derivatives also supported membrane biogenesis. This suggestion was confirmed by TEM of
HeLa cells expressing each derivative (panels 3CDm and 3CmD in Fig 10). The ultrastructure
of the membranes produced in 3CmD-expressing cells was different than observed for 3CD or
3CDm. In particular, the membranes exhibited a tubular organization and were not as clus-
tered and organized in appearance (compare enlargement of panel 3CmD to others in Fig 10).
Discussion
Phosphoinositides distinguish one organelle from another, couple activation of protein/
enzyme function to appropriate cellular localization, and, along with small GTPases and their
effectors, enable directional trafficking of proteins and membranes in the cell [17]. In the con-
text of this long-established paradigm of cell biology, the discovery that picornaviruses use
PI4P to target proteins to sites of genome replication was logical but also stunning [16]. Since
this transformative discovery was made, many laboratories have strived to fill in the gaps
between virus entry and formation of the PI4P-rich replication organelle. In the cell, PI4P bio-
genesis begins with GEF recruitment to the membrane to produce Arf-GTP, which, in turn,
recruits effectors that ultimately lead to the recruitment and/or activation of a PI4 kinase [19].
Fig 9. 3CD uses distinct mechanisms to induce different lipids. (A) PV infection induces PIP2. HeLa cells were infected with WT PV expressing EGFP at
an MOI of 10 and immunostained for PIP2 (red). EGFP (green) indicates infected cells, and DAPI (blue) marks the nuclei. PIP2 was quantified as
described for PI4P in the legend to Fig 1C. The averages of the normalized values were: 1.00 ± 0.05 (SEM) in mock-infected cells and 6.62 ± 0.37 (SEM) in
PV-infected cells. The difference was significant based on a Student’s t-test, which gave a P value of<0.0001. (B) PV infection induces PC. Experiment was
performed as described in panel A. Cells were immunostained for PC (red). PC was quantified as described for PI4P in the legend to Fig 1C. The averages
of the normalized values were: 1.00 ± 0.04 (SEM) in mock-infected cells and 3.03 ± 0.15 (SEM) in PV-infected cells. The difference was significant based on
a Student’s t-test, which gave a P value of<0.0001. (C) Induction of PIP2 by 3CD, 3CDm and 3CmD. HeLa cells were transfected with various 3CD mRNAs
and fixed 4 h post-transfection. Cells were immunostained for PIP2 (red) and 3CD (green). Nucleus was stained with DAPI (blue). Quantification of PIP2
intensity per cell was performed as described for PI4P in the legend to Fig 1C. The averages of the normalized values were: 1.00 ± 0.07 (SEM) in mock-
transfected cells; 4.37 ± 0.25 (SEM) in 3CD-transfected cells; 3.21 ± 0.16 (SEM) in 3CDm-transfected cells; and 3.82 ± 0.25 (SEM) in 3CmD co-transfected
cells. The level of PIP2 induction observed in 3CD (WT and mutant)-transfected cells was significant when compared to mock-transfected cells based on a
Student’s t-test, which gave a P value of<0.0001. For 3CD vs 3CDm, 3CD vs 3CmD and 3CDm vs 3CmD, a Student’s t-test yielded P values of 0.0002, 0.1264
and 0.0047, respectively. (D) Induction of PC by 3CD, 3CDm and 3CmD. Experiment was performed as in panel C. Cells were immunostained for PC (red)
and 3CD (green). Quantification of PC intensity per cell was performed as described for PI4P in the legend to Fig 1C. The averages of the normalized
values were: 1.00 ± 0.02 (SEM) in mock-transfected cells; 2.18 ± 0.07 (SEM) in 3CD-transfected cells; 1.89 ± 0.07 (SEM) in 3CDm-transfected cells; and
2.06 ± 0.10 (SEM) in 3CmD co-transfected cells. The level of PC induction observed in 3CD (WT and mutant)-transfected cells was significant when
compared to mock-transfected cells based on a Student’s t-test, which gave a P value of<0.0001. For 3CD vs 3CDm, 3CD vs 3CmD and 3CDm vs 3CmD, a
Student’s t-test yielded P values of 0.0041, 0.3129 and 0.1583, respectively.
https://doi.org/10.1371/journal.ppat.1007086.g009
In the specific case studied here, how GBF1 is recruited to membranes and the number and
identity of the factors between Arf1-GTP and PI4KB is unclear. However, our studies invoke a
requirement for 3CD instead of other P3-derived proteins (Fig 11A and 11B).
Conventional wisdom for picornavirology has been that recruitment of the kinase alone or
in complex with an unconventional host factor by the picornaviral 3A protein is sufficient to
remodel the lipid composition of the replication organelle, formation of which must occur by
unrelated mechanisms and directed by other viral factors [16,25–29] (Fig 11C and 11D). Our
study challenges this paradigm by showing that a single viral protein, the 3CD protein, is suffi-
cient to promote membrane biogenesis in the area of the cell between the ER and Golgi, the
so-called ER-Golgi intermediate compartment (ERGIC) (Fig 10). These membranes contain
the expected PC (Fig 9B and 9D) and are enriched in PI4P (Fig 1) and PIP2 (Fig 9A and 9C).
Importantly, 3CD-induced changes to levels of PC, PI4P, and PIP2 appear to be a deliberate
process instead of a transcriptional response to stress (Figs 2A and S5A and S5B).
The mechanism used by 3CD to induce PI4P is the GBF1•Arf1-GTP•PI4KB pathway (Figs
2C–2E, 3 and 4), the normal cellular pathway instead of a virus-contrived pathway. Connec-
tions between 3CD and this pathway were made years ago in cell-free systems [52]; however,
the field was enthralled by the road less traveled and pursued mechanisms dependent on 3A.
Our genetic analysis suggests that 3CD functions both before and after Arf1 activation (Fig 6).
The 3D domain contributes to events before Arf1 activation; the 3C domain contributes to
events after Arf1 activation (Fig 6). We propose that 3CD hijacks the pathway by infiltrating
its two black boxes: (1) recruitment of GBF1 to membranes; (2) recruitment of the effector(s)
responsible for PI4KB activation (Fig 11B). Both of these recruitment functions of 3CD would
Fig 10. 3CD induces membrane biogenesis in the perinuclear region of the cell in the vicinity of the Golgi. HeLa cells were transfected with EGFP or the indicated
3CD mRNA and then processed for transmission microscopy (TEM) 4 h post-transfection. Electron micrograph of a EGFP-transfected cell (left panel) shows the
normal ultrastructure of the cell. The nucleus is indicated (N). The Golgi apparatus is located in the perinuclear region of the cell (black box). The comparable view of
3CD-transfectd cell shows proliferation of membranes in the area normally occupied by the Golgi apparatus (red, blue, and green boxes). The second row of images
shows magnifications of the areas highlighted above by the colored boxes. Scale bar indicates 1 μM.
https://doi.org/10.1371/journal.ppat.1007086.g010
Fig 11. Roles of poliovirus P3-encoded proteins in biogenesis and phospholipid composition of the replication organelle. (A) The P3 precursor
polyprotein is cleaved by the 3C-encoded protease activity by two distinct pathways: major and minor. Therefore, proteins 3AB and 3CD are present
at substantially higher levels in an infected cell than products of the minor pathway. (B) 3CD hijacks the GBF1-Arf1-PI4KB pathway to induce PI4P
biosynthesis. How 3CD recruits GBF1 to the membrane remains unclear. This recruitment event leads to Arf1 activation and is sensitive to golgicide
A (GCA). Alteration of the back of the thumb of the 3D domain of 3CD (3CDm) interferes with Arf1 activation. Post-Arf1 activation, PI4KB is
recruited to membranes and is itself activated for synthesis of PI4P. PI4P biosynthesis is inhibited by the PI4KB inhibitor, PIK93. Steps leading to
recruitment and/or activation of PI4KB require the 3C domain of 3CD and are defective in 3CmD. The ability of 3CDm and 3CmD to complement
the other (Fig 6) suggests that 3CD functions minimally at two discrete steps (black boxes). Importantly, these black boxes represent the least
benefit from the ability of 3CD to bind to membranes, an activity reported here to be depen-
dent on PI4P (Fig 8). Identification of the 3CD-interacting factors responsible for PI4P induc-
tion may illuminate the mechanism and regulation of the cellular pathway.
The ability of 3AB to promote loss of PI4P from the Golgi (Fig 1B) without interfering with
Golgi integrity (Fig 1D) was a surprise. It is known that 3A interacts with GBF1, and the sug-
gestion has been made that the 3A-GBF1 interaction inhibits anterograde transport from
ERGIC to Golgi, thus promoting dissolution of the Golgi (Fig 11D) [24]. For this outcome to
occur, transport from ERGIC would have to be impacted instead of transport within the Golgi.
Our assumption was that 3A and 3AB functions overlapped. They do not. 3A also promotes
loss of PI4P from the Golgi (Fig 1B), but this loss likely reflects disruption of Golgi integrity
(Figs 1D and 11D). It is known that 3A interacts with membranes differently than 3AB (Fig
11C) [53]. This physical difference may explain the functional difference observed here. Levels
of 3AB in the infected cell greatly exceed levels of 3A (Fig 11A); therefore, functions of 3A may
appear only at late times post-infection as the amount of 3A in the cell rises [46].
What we observe perhaps for 3AB is inhibition of GBF1 or PI4KB at the Golgi, the conse-
quence of which may only be inactivation of the normal pathway for maintenance of PI4P lev-
els (Fig 11E). Such a mechanism would have the advantage of depleting all PI4P that could
misdirect localization of viral proteins, and simultaneously make all GBF1-mediated PI4P syn-
thesis strictly dependent on 3CD. Consistent with such a model is the observation that 3CD is
able to overcome the inhibitory action of 3AB on PI4P levels (Figs 7 and 11E), but not the
action of 3A on PI4P levels (Fig 7). 3AB was much more efficient at clearing PI4P from the
Golgi than the PI4KA/B inhibitor, PIK93 (compare PI4P in the 3AB column of Fig 1B to PI4P
in the +PIK93 column of Fig 2E). This difference may reflect the fact that PI4P levels at the
Golgi are maintained not only by PI4KB but also by PI4KIIα [18,54]. Indeed, PI4KIIα is
responsible for as much as 50% of the PI4P found in cells [54]. This PI4 kinase is not a reported
target of PIK93, but our data would suggest that it is a target of 3AB.
Several studies have been published recently reporting that enteroviruses can adapt to
growth in the presence of PIK93 [6,55,56]. The suggestion of one group is that induction of
PI4P biosynthesis is not absolutely essential for enterovirus genome replication. As discussed
above, type III PI4 kinases may not be the only kinases contributing to PI4P biosynthesis as
PIK93 is not able to completely abolish induction of PI4P biosynthesis by 3CD (Fig 2E and
2F). Resistance to PIK93 maps to 3A-coding sequence, and several alleles have been described
[6,55,56]. These substitutions dysregulate processing of 3AB, leading to production of elevated
levels of 3A [6,55,56]. Importantly, one group suggests that loss of 3AB correlates with
increased levels of PI4P in infected cells in the presence of PIK93 [55]. It is possible that 3A
understood aspects of the normal pathway of PI4P biosynthesis: recruitment of GBF1 to membranes and recruitment of PI4KB to membranes and
its subsequent activation. Identification of the cellular targets of 3CD may illuminate the cellular proteins participating in these black boxes of the
normal cellular pathway of PI4P biogenesis. Biosynthesis of both PIP2 (PI4,5P2) and PC is also induced by 3CD. Induction of the synthesis of these
lipids occurs by mechanisms distinct from that of PI4P as both 3CDm and 3CmD retain the capacity to cause elevation of these lipids (Fig 9).
Essentially nothing is known about how 3CD might induce the biosynthesis of these lipids, hence the big red question mark. However, as for PI4P
biosynthesis, a non-genomic mechanism of induction is predicted by the inability of actinomycin D to interfere with induction of the biosynthesis of
these lipids (Figs 2A, S5A and S5B). (C) The interaction of 3A with membrane spans the bilayer but that of 3AB does not. These differences in
interaction with membrane may give rise to the functional differences reported herein. (D) It is well established that 3A interferes with GBF1
activation causing dissolution of the Golgi. The literature is rife with examples of 3A impacting localization and/or activity of PI4K either directly or
in collaboration with ACBD3. Our studies reveal loss of PI4P in the presence of 3A. Whether or not this is caused by dissolution of the Golgi or
active interference with PI4K activation or catalysis is not known. None of the activities of 3A can be modulated by the presence of 3CD. (E) 3AB
showed no substantive change to Golgi integrity, so interactions with GBF1 may not occur. Golgi-associated PI4P was depleted in the presence of
3AB. It is not known if this outcome requires an interaction with PI4K, requires interference with PI4K activation and/or catalysis, or uses a PI4K-
independent mechanism. What is clear, however, is that the ability of 3AB to interfere with steady-state levels of PI4P is suppressed completely in the
presence of 3CD.
https://doi.org/10.1371/journal.ppat.1007086.g011
and/or the 3AB derivatives with PIK93-resistance-conferring substitution are unable to inter-
fere with PI4P biosynthesis as well as wild-type 3A or 3AB (Fig 1B and 1D). If this is the case,
then resistance to PIK93 does not demonstrate the absence of a need for PI4P but the ability of
the virus to shift from utilizing a type III PI4 kinase to another class of PI4 kinases for PI4P
biosynthesis.
Both the observation that PV infection induced PIP2 (Fig 9A) and the observation that
3CD alone was sufficient for induction of PIP2 (Fig 9C) were surprises. The existence of
plasma membrane-localized pools of PIP2 have been known and studied for a long time [57].
More recently, it has become clear that PIP2 is contained within many intracellular compart-
ments, including ER, Golgi, endosomes and lysosome, and regulates intracellular membrane
trafficking, including endolysosomal and autophagic vesicles [57]. Binding of PIP2 to ATG14,
a component of the phagophore-inducing PI3 kinase complex, promotes initiation of autop-
hagy [58]. Autophagy contributes substantively to the multiplication of picornaviruses, espe-
cially enteroviruses like poliovirus [59–68]. This pathway is thought to be responsible for the
non-lytic egress of virus particles. Perhaps 3CD-induced PIP2 during PV infection contributes
to formation, function and/or trafficking of the phosphatidylserine-enriched phagophores that
engulf PV virions to produce vesicles thought now to be important for viral transmission [69].
Much remains to be learned about PIP2 synthesis during PV infection. PIP2 can be pro-
duced from PI4P by a PI4P-5-kinase (PIP5K) or from PI5P by a PI5P-4-kinase (PIP4K) [17].
There are multiple genes for each class; alternative splicing of PIP5K transcripts creates even
more isoforms [17]. PIP2-producing kinases are even less well understood than the PI4P-pro-
ducing kinases [17]. However, PIP2-producing kinases appear to be activated by small
GTPases that are regulated by GEFs. Therefore, it is reasonable to propose that the role of 3CD
in the mechanism of PIP2 induction will be conceptually similar to that reported here for PI4P
induction. 3CD may act upstream of a GEF and downstream of an activated small GTPase to
recruit and/or activate the PIP2-producing kinase. The mechanism remains to be defined.
The question of which class of kinases is used will need to be addressed by future experi-
ments. Our observation that 3CD derivatives that fail to induce synthesis of PI4P (Figs 6 and
S3) retain the ability to induce synthesis of PIP2 (Figs 9 and S5) suggest that 3CD-directed
synthesis of PI4P is not required for PIP2 synthesis. If PI4P is the substrate, then a PIP5K (also
referred to as a type II PIPK) would be required. The α and β isoforms of PIP5K reside in the
nucleus, and the γ isoform resides in the ER [17,70]. Any or all of these isoforms are feasible
candidates in the context of infection because PV infection actually leads to dysregulation of
nuclear import and breakdown of the nuclear envelope [71]. In 3CD-transfected cells, it is con-
ceivable that nuclear forms could also be hijacked. 3CD enters the nucleus and could establish
sites of PIP2 production at sites of contact between the nucleus and ER [36].
PI4P is also required for multiplication of hepatitis C virus (HCV) [72–74]. Non-structural
protein 5A (NS5A) is required for maintenance of high levels of PI4P in Huh-7 cells and sub-
lines thereof replicating HCV RNA [75–77]. This activity is mediated by an interaction
between NS5A and PI4KA [76]. Inhibitors disrupting the NS5A-PI4KA interaction are potent
inhibitors of HCV multiplication in cell culture and in vivo [75,76].
PIP2 is required by other viruses, although there is a paucity of reports of virus-induced
synthesis of PIP2. Binding of PIP2 to NS5A has been shown to promote interactions between
NS5A and a host factor required for genome replication [78]. In most other cases, PIP2 is used
for some aspect of virion assembly. For example, PIP2 binding to the matrix protein domain
of the retroviral Gag polyprotein sends the protein to the plasma membrane as a step in virion
assembly [79]. PIP2 binding to the matrix protein (VP40) of Ebola virus is an essential step in
virion assembly at the plasma membrane [80]. PIP2 binding to the NP protein of influenza
virus in the context of the viral ribonucleoprotein (vRNP) harboring the genome targets the
vRNP to the plasma membrane for incorporation into virions [81]. In all of these cases endog-
enous levels of plasma-membrane associated PIP2 appear sufficient. Use of PIP2 by PV and
related viruses for virus assembly fits nicely into this existing paradigm but a mechanism for
induction of PIP2 in the cell appears to be required.
In a recent study using representative members of the major supergroups of positive-strand
RNA viruses of plants and animals, it was demonstrated that PC is induced by all of the viruses
studied, including PV [50]. The mechanism of PC induction used by brome mosaic virus
involved recruitment of one PC biosynthetic enzyme and activation of another but details are
lacking [50]. Nothing is known about how PV might induce PC. Our inclusion of PC in this
study initially was as a negative control. To the best of our knowledge, no pathway using a
GEF or a small GTPase is known that leads directly to activation of the enzyme governing the
rate-limiting step of PC biosynthesis, CTP: phosphocholine cytidylyltransferase (CCT).
Recruitment of CCT to membranes may be sufficient for activation of the enzyme, which
could be accomplished by direct interaction with 3CD or a CCT-interacting protein [49]. The
observation that 3CD expression caused PC induction motivated us to consider the possibility
that phospholipid imbalances resulting from PI4P and/or PIP2 induction triggered a stress
response that turned on transcription of genes required for membrane biogenesis. However,
the resistance of 3CD-mediated induction of PC to AMD is inconsistent with a transcriptional
response (S5B Fig). We suggest the existence of a post-transcriptional or post-translational
mechanism that permits cells to respond to an acute need for membrane biogenesis. Perhaps
studies of 3CD-mediated induction of PC will illuminate the mechanism.
How is it that a single, viral protein can have so many functions interfacing with host path-
ways required for phospholipid metabolism and membrane biogenesis, function at the heart of
genome replication by binding to all of the cis-acting replication elements for initiation, and
also cleave the viral polyprotein to activate viral function and cleave host factors to hijack host
ribosomes and antagonize host innate defenses? Our studies of 3CD structure and dynamics
have revealed a panoply of conformations achieved by rotating the 3C domain relative to the
3D domain. Each of these conformations have been suggested to expand the proteome and
provide unique surfaces for interaction with viral and/or host proteins and nucleic acids [82].
The competency to manipulate the 3CD proteome in a deliberate manner would facilitate elu-
cidation of 3CD-interaction network and uncover mechanisms diluted by the ensemble of
states. Understanding the mechanisms used by 3CD to induce these profound changes in the
cell will likely illuminate regulatory hubs for membrane biogenesis that have undoubtedly not
only been usurped by picornaviruses but other families of RNA viruses as well. Poliovirus and
its cousins still hold many secrets of mammalian cell biology for future studies to expose.
Materials and methods
Cells and culture conditions
HeLa cells (CCL-2) were purchased from American type culture collection (ATCC) and cul-
tured in Dulbecco’s Modified Eagle Medium: Ham’s nutrient mixture F-12 (Gibco) supple-
mented with 10% heat-inactivated fetal bovine serum (Atlanta Biologics) and 1% Penicillin-
Streptomycin (Corning). All experiments were performed at 37˚C in 5% CO2.
Antibodies and other reagents
Antibodies for staining PI4P and PI(4,5)P2 were purchased from Echelon Biosciences. Anti-
Giantin, anti-Calnexin and anti-GBF1 were from Abcam. Anti-PI4KB and anti-Nucleolin
were from BD Biosciences and Novus biologicals, respectively. Anti-Arf1 antibody was a gen-
erous gift from Dr. Sylvain Bourgoin at Laval University, Canada. Anti-phosphatidylcholine
(PC) antibody was provided by Dr. Umeda at Tokyo University, Tokyo. Antibodies against PV
3D and 3AB were produced in Cameron lab. All secondary antibodies used for immunofluo-
rescence were purchased from Molecular Probes. Secondary antibody for Western blotting
was purchased from SeraCare. Inhibitors used in this study including brefeldin A (BFA), golgi-
cide A (GCA), PIK93 and actinomycin D (AMD) were purchased from Sigma-Aldrich.
Construction of vectors for ectopic expression of proteins
Plasmids used for ectopic expression of proteins were constructed by amplifying the gene of
interest using pRLuc-RA plasmid as template and using oligonucleotide pairs provided in S1
Table. The resulting PCR product was ligated into the pIRES vector (Clonetech) backbone
between the EcoRI and NotI unique sites. This caused a loss of the IRES element from the
pIRES. To avoid confusion with nomenclature, these cloned plasmids were designated pSB
vectors. For making pSB-EGFP, the pEGFP-N1 plasmid was digested with EcoRI and NotI.
The resulting EGFP fragment was then ligated into the pIRES backbone between the EcoRI
and NotI unique sites. Quickchange mutagenesis was used to construct the mutant 3CD genes
carrying point mutations in 3C and 3D using the oligonucleotide pairs provided in S1 Table.
In order to inactivate 3C protease activity, the catalytic cysteine (C147) was converted to gly-
cine. The clones were verified by sending to the sequencing facility at The PSU Genomics
Core Facility.
Engineering luciferase subgenomic replicons with mutations in 3C
Subgenomic luciferase-encoding replicons harboring point mutations were constructed by
overlap extension PCR using the oligonucleotides listed in S1 Table. For both reactions,
pRLuc-HpaI-SacII was used as the template [31]. The resulting overlap PCR fragment was
digested and ligated in between the HpaI and SacII sites of the pRLuc-HpaI-SacII vector to
produce the pRLuc plasmids with desired mutations.
In vitro transcription
Linearization of cDNA and transcription was performed as described previously [30]. Briefly,
the pSB- and pRLuc- plasmids were linearized with NotI or ApaI and purified with QIAEX II
suspension (QIAGEN) following the manufacturer’s protocol. RNA was then produced using
the linearized plasmid in a 20 μL reaction containing 350 mM HEPES pH 7.5, 32 mM magne-
sium acetate, 40 mM dithiothreitol (DTT), 2 mM spermidine, 28 mM nucleoside triphosphates
(NTPs), 0.025 μg/μL linearized DNA, and 0.025 μg/μL T7 RNA polymerase. The reaction mix-
ture was incubated for 3 h at 37˚C and magnesium pyrophosphate was removed by centrifuga-
tion for 2 min. The supernatant was transferred to a new tube and subjected to RQ1 DNase
treatment for 30 min at 37˚C. RNA quality was verified by agarose gel (0.8%) electrophoresis.
RNA capping and polyadenylation
The in vitro transcribed pSB-RNAs were purified using the RNeasy kit (QIAGEN) using the
manufacturer’s protocol and subjected to modification by adding a 5’-end cap and a 3’-end
poly(A) tail using the T7 mRNA production kit (Cellscript) following the manufacturer’s pro-
tocol. The modified RNAs were further purified using the RNeasy columns and quality was
evaluated on a 0.8% agarose gel. The addition of poly(A) tail was confirmed by comparing the
modified RNA to unmodified RNA.
mRNA transfection
2.5 X105 HeLa cells were seeded on coverslips in 6-well plates and transfected 16 h post-seed-
ing. For pSB-mRNAs, 2 μg of column-purified transcripts were transfected using Transmes-
senger transfection kit (QIAGEN) following the manufacturer’s protocol. For pRLuc-RNAs,
transfections were performed using 2.5 μg of column purified RNA following the TransIT
transfection reagent (Mirus) and corresponding protocol. In all cases, cells were incubated at
37˚C and subjected to immunostaining 4 h post-transfection. For studies with inhibitors,
transfections were performed in presence of the inhibitors: AMD (5 μg/mL); BFA (2 μg/mL);
GCA (10 μM) and PIK93 (15 μM) and the inhibitors were kept on the monolayers for the
entire 4 h period.
Virus infection
2.5 X 105 HeLa cells were seeded on coverslips in 6-well plates overnight. Cells were infected at
confluency with PV at an MOI of 10, in the presence or absence of 3mM GuHCl. The inhibitor
was used on cells when adding the virus for a 30min period as well as the 4-hour incubation
immediately after.
Indirect immunofluorescence
Cells were fixed 4 h post-transfection using 4% formaldehyde in PBS for 20 min followed by
washing in PBS and permeabilizing with 20 μM digitonin for 10 min. Digitonin was washed
off with three washes of PBS. Cells were then blocked with 3% BSA in PBS for 1 h and incu-
bated with primary antibodies for 1 h. Following washes cells were incubated with the second-
ary antibodies for 1 h. For PIP2 membrane staining, the protocol described in Hammond et al.
2009. [51] The processed coverslips were mounted on glass slides using VECTASHIELD
Mounting Medium with DAPI (Vector Laboratories). The mounted coverslips were sealed
with nail polish. Samples were imaged using Zeiss Axiovert 200 M epifluorescence
microscope.
Primary antibodies used were: anti-Giantin (1:400) for Golgi staining; anti-Calnexin
(1:500); anti-Nucleolin (1:200) for nucleolar staining; anti-PI4P (1:200); anti-PI(4,5)P2 (1:200);
anti-PC (1:40); anti-3AB (1:400) and anti-3D (1:100); anti-Arf1 (1:200); anti-GBF1 (1:200);
anti-PI4KB (1:100). All dilutions were made in the blocking buffer.
Image processing
For fluorescence intensity quantifications, each image was acquired as a Z-stack file with
Z = 11 slices.The sum of intensities was measured using the ZEN 2012 (blue edition) software
from Zeiss. The sum fluorescence intensity for each cell was normalized against the average of
the sum fluorescence intensities of mock cells.
Preparing GST-GGA3 glutathione-sepharose beads
BL21-DE3 cells were transformed using a GST-GGA3 expression vector [40]. Transformed
cells were plated on NZCYM media containing ampicillin (100μg/ mL) and incubated at 37˚C
overnight. BL21-DE3 cells harboring the GST-GGA3 expression vector were then grown over-
night in 50 mL NZCYM/Amp at 37˚C. The culture was back-diluted at a 1:25 ratio in 500 mL
NZCYM/Amp media and grown at 37˚C until the culture reached 0.4–0.6 OD600. Expression
of GST-GGA3 was then induced by addition of IPTG to 1 mM and incubated at 37˚C for 6 h.
The cell pellet was harvested by centrifugation at 6000 rpm for 10 mins. The pellet (1.8 g) was
suspended in 13 mL ice cold bacterial lysis buffer (BLB) containing 50 mM Tris, pH 8.0, 20%
sucrose, 10% glycerol, 2 mM DTT, 0.1 mM PMSF and 1 μg/mL each of pepstatin and leupep-
tin. Cells were lysed using a French press (Glen Mills), and cell debris was removed by centri-
fugation at 25,000 rpm for 30 min at 4˚C. Glutathione-sepharose beads (250 μL) were
equilibrated with BLB, by four sequential washes with 1 mL of BLB. Beads were collected after
each wash by centrifugation at 400 X g for 2 min at 4˚C. Beads were added to the clarified
lysate and incubated at 4˚C for 1 h on a rotating shaker. The beads were then pelleted by cen-
trifugation at 200 X g for 30 min and washed six times in 15 mL of BLB. Finally, the beads were
suspended in 400 μL of BLB with containing DTT (1 mM). The protein yield was estimated by
Bradford assay using BSA as a standard. Beads were aliquoted (40 μg/ tube) for single use and
stored at -80˚C.
Detection of Arf1-GTP in cells using a GST-GGA3 pull-down assay
Activation endogenous Arf1 by transfection of mRNA or by infection was monitored using
GST-GGA3 pull-down assay described in [41] with minor changes. Cells were plated at a den-
sity of 3 X 106 cells in 100 mm dish 24 h prior to transfection or infection. 3CD (WT or
mutant) mRNA (15.5 μg) was transfected into HeLa cells using TransIT-mRNA transfection
kit (Mirus). Four hours post-transfection or post-infection cells were lysed at 4˚C in 0.5 mL of
lysis buffer (50 mM Tris, pH 7.5, 200 mM NaCl, 10 mM MgCl2, 0.1% SDS, 0.5% sodium deox-
ycholate, 1% triton X-100, 5% glycerol with 0.1 mM PMSF and 1 μg/mL each of pepstatin and
leupeptin).
Lysates were incubated on ice for 5 min in presence of 50 μL of CL-4B Sepharose beads (per
sample) and then centrifuged for 15 min at 16,000 X g and 4˚C. The clarified lysate (500 μg)
was incubated with 40 μg of GST-GGA3 bound to Glutathione Sepharose beads for 1 h on a
rotating shaker at 4˚C. The beads were then washed three times with 1 mL cold lysis buffer fol-
lowed by a final wash in 1 mL cold PBS (1X). Liquid was removed beads by quick inversion fol-
lowed by and a 30 s spin at 6,000 X g at 4˚C and removal of residual buffer using a pipetman.
Bound proteins were eluted from beads by adding 30 μL of 2X SDS-PAGE sample buffer and
incubating at 65˚C for 10 min. Beads were pelleted by centrifugation at 6,000 X g for 2 min at
room temperature. Twenty μL of the supernatant was resolved by SDS polyacrylamide gel elec-
trophoresis. Endogenous, activated Arf1 was detected using anti-Arf1 antibody. For Total Arf1
was detected using the same antibody, but the sample was prepared from 10 μg of the clarified
lysate. Alkaline phosphatase activity associated with the secondary antibody was detected
using the ECF reagent (GE Healthcare) and quantified by imaging the fluorescence signal
using the Syngene G-box.
Luciferase activity assay
Luciferase assays were performed as described previously [30] with the following modifica-
tions. Subgenomic replicon RNA (5 μg of in vitro transcribed RNA) was electroporated into
HeLa cells. The cells were incubated in normal growth media (DMEM/F12 supplemented with
10% fetal bovine serum, 1% penicillin/streptomycin, 5 mL/1 × 106 cells) and 1 × 105 cells were
harvested and lysed using 100 μL of 1X cell culture lysis reagent (CCLR, Promega) at the indi-
cated times post-electroporation. Luciferase activity was measured by adding equal volume of
firefly luciferase assay substrate (Promega) to cell lysate and the reaction mixture was applied
to a Junior LB 9509 luminometer (Berthold Technologies) to read relative light units (RLU)
for 10 s. Relative light units (RLU) were then normalized based on the total protein concentra-
tion determined by Bio-Rad protein assay reagent (BioRad) for each sample.
Transmission electron microscopy
HeLa cells were transfected with mRNAs expressing PV-3CD or EGFP and 4 h post-transfec-
tion cells were fixed and embedded for TEM studies as described previously [31]. Briefly, cells
were harvested and fixed with 1% glutaraldehyde, washed with 0.1 M cacodylate (sodium
dimethyl arsenate, Electron Microscopy Sciences) twice for 5 min each, incubated in 1%
reduced osmium tetroxide containing 1% potassium ferricyanide in 0.1 M cacodylate for 60
min in the dark with one exchange and washed two times with 0.1 M cacodylate again. En bloc
staining was performed with 3% uranyl acetate in 50% ethanol for 60 min in the dark. Dehy-
dration was carried out with different concentrations of ethanol (50, 70, 95 and 100% for 5–10
min) and 100% acetonitrile. Embedding was performed overnight with 100% Epon at 65˚C.
The embedded sample was sectioned with a diamond knife (DiATOME) to slice 60–90 nm
thickness by using ultra microtome (Reichart-Jung). The sectioned sample was placed on cop-
per grid (Electron Microscopy Sciences), stained with 2% uranyl acetate in 50% ethanol fol-
lowed by lead citrate staining for 12 min. The grid was washed with water and the grid was
dried completely. The image was obtained using FEI Tecnai G2 Spirit BioTwin located in The
PSU Electron Microscopy Facility.
Supported lipid bilayer (SLB) binding experiments
A microfluidic platform was employed to test the interaction between the viral protein and 7.5
mol% PI4P SLBs. SLBs containing 99.5 mol% POPC and 0.5 mol% oSRB-POPE, a pH-sensi-
tive fluorescent probe conjugated to a lipid, served as a negative control. Synthesis of oSRB-
POPE was described previously [44]. A PDMS block was fused to a borosilicate glass by use of
a plasma-oxygen treatment. The fabrication of the PDMS device was described previously
[44]. SLBs were formed on the borosilicate glass of each micro channel by spontaneous fusion
and rupturing of the SUVs after treatment with 0.2 N HCl [47]. Running buffer (20 mM
HEPES, 100 mM NaCl, pH 7.0) was flowed through each channel for 30 min remove excess
vesicles. In order to equilibrate the SLBs to the experimental condition, running buffer con-
taining the appropriate dilution of gel filtration buffer (20 mM HEPES, 20% glycerol, 1 mM
BME, 500 mM NaCl, pH 7.0) was flowed through the channels. The fluorescence intensity
obtained post-equilibration step served as a reference for each channel. PV-3CD dilutions
were prepared using the running buffer. PV-3CD was flowed until the fluorescence intensity
in each channel stabilized (30–45 min). Change in fluorescence intensity, normalized to the
reference (no protein) channel, was plotted as a function of PV-3CD concentration and then




where, Fmax represents the normalized fluorescence intensity value at saturation level and
Kd,app represents the apparent dissociation constant. Graphs were generated by GraphPad
Prism v.6 software. Error bars represent the SEM.
Images were taken with an Axiovert 200M epifluorescence microscope (Carl Zeiss Micros-
copy) equipped with a AxioCam MRm camera (Carl Zeiss Microscopy) and X-Cite 120
(Excelitas Technologies Corp.) light source was used to take fluorescence images. A 10X air
objective was used for imaging along with Alexa 568 filter set (Carl Zeiss Microscopy) with an
excitation and emission at 576 nm and 603 nm, respectively. Exposure time was set to 200
msec per exposure with minimal times of exposure throughout experiments. AxioVision LE64
v.4.9.1.0 software (Carl Zeiss Microscopy) was used to process the images.
Expression and purification of 3CmD and 3CDm
pSUMO plasmids encoding 3CDm or 3CmD was transformed into Rosetta (DE3) competent
cells [83]. Cells were grown to an OD of 1.0, harvested by centrifugation (5,400 x g, 10 min,
4˚C), and washed with 30 mL of buffer (10 mM Tris and 1 mM EDTA, pH 8.0) per liter of bac-
terial culture, and re-centrifuged. Each gram of cell pellet was suspended in 5 mL of lysis buffer
(20 mM HEPES, 10% glycerol, 5 mM imidazole, 10 mM β-mercaptoethanol [BME], 500 mM
NaCl, 1 mM EDTA, 1.4 μg/mL pepstatin A, 1.0 μg/mL leupeptin, pH 7.0). Suspended cells
were homogenized by a Dounce homogenizer and lysed by two passes through a French press
at a pressure of 1,000 psi. Phenylmethylsulfonyl fluoride (PMSF) was added to the cell lysate at
a final concentration of 1 mM. The suspension was clarified by centrifugation (74,000 x g, 30
min, 4˚C). The supernatant was loaded onto a Nickel-nitrilotriacetic (Ni-NTA) resin (Thermo
Fisher Scientific Inc.), which was previously equilibrated with 10 column volumes (CV) of
equilibration buffer containing 5 mM imidazole at 1 mL/min using a peristaltic pump. The
protein load was passed through the equilibrated Ni-NTA resin at 1 mL/min. To remove con-
taminants, the loaded resin was washed with 50 CV and 4 CV of equilibration buffer (20 mM
HEPES, 20% glycerol, 10 mM β-mercaptoethanol (BME), 500 mM NaCl, pH 7.0) containing 5
mM and 50 mM imidazole, respectively. PV-3CD was eluted into multiple fractions using
equilibration buffer containing 500 mM imidazole. Fractions were evaluated by Coomassie
stained SDS-PAGE (10.0%) gel. Concentrated fractions were pooled, treated with 1 μg ubiqui-
tin-like-specific-protease 1 (ULP-1) per 1 mg protein of interest, and dialyzed against gel filtra-
tion buffer (20 mM HEPES, 20% glycerol, 1 mM BME, 500 mM NaCl, pH 7.0) overnight at
4˚C using a 12–14 kDa MWCO dialysis membrane (Spectrum Laboratories). Dialyzed PV-
3CD sample was centrifuged (74,000 x g, 30 min, 4˚C) to ensure non-aggregated protein, and
subsequently concentrated to 2–5 mL for loading onto a gel filtration column (GE Healthcare).
The gel filtration column was run at 1.0 mL of gel filtration buffer per minute, and divided
into 34 3-mL fractions. Fractions with the protein of interest were pooled and concentrated
with a Vivaspin Turbo 15 (Sartorius, 10 kDa MWCO). The protein concentration was deter-
mined by measuring the absorbance at 280 nm (εmax = 0.08469 μM-1cm-1) with a NanoDrop
(Thermo Fisher Scientific Inc). The ionic strength of the dialyzed protein solution was con-
firmed with a conductivity meter (Control Company). To assess extraneous protein contami-
nation, dynamic light scattering (DLS) experiments performed with Viscotek 802 DLS
instrument at 20˚C. Agarose gel electrophoresis was run to check for any contaminating
nucleic acids. Flash frozen aliquots were stored at -80˚C.
Statistical analysis
For statistical analysis data were plotted as means ± SEM. The intensity comparisons between
control and experimental measurements used an unpaired Student’s t-test in the GraphPad
Prism software. The means and P values for pairwise comparisons of all experiments are pro-
vided in S2 Table, a subset of these are also presented in the appropriate figure legends.
Supporting information
S1 Fig. Poliovirus infection causes activation of Arf1. (A) HeLa cells were infected with WT
PV at an MOI of 10. A lysate was prepared 4 h post-infection and used for an GST-GGA3-
pull-down assay as outlined in Fig 3A. with subsequent Western blotting and detection using
anti-Arf1 antibody. Arf1-GTP (bead-eluted material) and total Arf1 (from unfractionated
lysate) were detected by Western blot using the indicated antibodies and enhanced chemi-
fluorescence. (B) The magnitude of Arf1 activation was determined by quantifying the fluores-
cence intensity of Arf1-GTP and total Arf1 and reporting the quotient thereof. The averages of
the values for the quotients (n = 4) were: 1.27 ± 0.14 (SEM) in mock-infected cells and
8.37 ± 0.03 (SEM) in WT PV-infected cells. The difference was significant based on a Student’s
t-test, which gave a P value of 0.0001.
(PDF)
S2 Fig. Changes to Arf1, GBF1, and PI4KB caused by 3CD are also observed during PV
infection. (A) HeLa cells were infected with PV at an MOI of 10. Four hours post-infection,
cells were immunostained for the following: (i) 3D/3CD (ii) Arf1, (iii) GBF1, or (iv) PI4KB
(green). Infected cells were identified by changes to pattern of PI4P expression (red). The
nucleus was stained with DAPI (blue). (B) Experiment performed as above immunostained
for the following: (i) Arf1, (ii) GBF1, or (iii) PI4KB (green). Infected cells were identified by
3D/3CD expression (red). The nucleus was stained with DAPI (blue). (C) Experiment per-
formed as above immunostained for the following: (i) Giantin or (ii) Calnexin (green).
Infected cells were identified by 3D/3CD expression (red). The nucleus was stained with DAPI
(blue).
(PDF)
S3 Fig. Additional 3CD variants with substitutions in the 3C domain exhibit defects to
PI4P induction caused by a block at a step post-Arf1 activation. (A) The indicated 3CD
derivatives were expressed individually in HeLa cells and immunostained for the presence of
PI4P (red) and 3CD (green). The nucleus was stained with DAPI (blue). Neither 3CD deriva-
tive altered the level of PI4P or its localization. (B) Quantification of PI4P intensity per cell
(n = 20) was performed as described in the legend to Fig 1C. The averages of the normalized
values were: 1.06 ± 0.02 (SEM) in mock-transfected cells; 1.09 ± 0.06 (SEM) in 3CR13LD-trans-
fected cells; 0.95 ± 0.05 (SEM) in 3CR84LD -transfected cells. The level of PI4P induction
observed in 3CD mutant-transfected cells was not significant when compared to mock-trans-
fected cells based on a Student’s t-test. (C) Activation of Arf1 by the 3CD derivatives was deter-
mined as described in the legend to Fig 3A. Both derivatives induced activation of Arf1. (D)
The magnitude of Arf1 activation was determined as described in the legend to Fig 3B. The
averages of the values for the quotients (n = 3) were: 0.43 ± 0.03 (SEM) in mock-transfected
cells; 1.23 ± 0.18 (SEM) in 3CR13LD-transfected cells; 1.50 ± 0.15 (SEM) in 3CR84LD-trans-
fected cells. For mock vs 3CR13LD, mock vs 3CR84LD and 3CR13LD vs 3CR84LD, a Student’s t-
test yielded P values of 0.0112, 0.0024 and 0.3169, respectively. (E) Complementation of
3CR13LD- or 3CR84LD-expressing subgenomic replicons by 3CD-GAA. HeLa cells were trans-
fected with replicon RNA indicated in the key. GAA refers to a replicon expressing a catalyti-
cally inactive 3D-encoded polymerase; the corresponding 3CD-GAA should function
normally in PI4P induction. Luciferase activity was measured every hour post-transfection as
indicated.
(PDF)
S4 Fig. Specificity of the anti-PIP2 antibody. PIP2 is located at the plasma membrane and
can only be detected in naïve HeLa cells at 0˚C [51]. We confirm the activity and specificity of
the antibody used in this study by immunostaining for PIP2 (red) at 0˚C. The nucleus was
stained with DAPI (blue).
(PDF)
S5 Fig. Induction of PIP2 and PC biosynthesis by 3CD is not sensitive to actinomycin D
and does require induction of PI4P biosynthesis. Effect of actinomycin D (AMD) on 3CD-
mediated induction of PIP2 (A) and PC (B). HeLa cells were maintained in the absence or
presence of AMD (5 μg/mL) prior to transfection with 3CD mRNA. Cells were immunos-
tained for PIP2 or PC (red) and 3CD (green); the nucleus was stained with DAPI (blue). The
presence of AMD did not interfere with induction of PIP2 or PC. (C) The indicated 3CD
derivatives were expressed individually in HeLa cells and immunostained for the presence of
PIP2 (red) and 3CD (green). The nucleus was stained with DAPI (blue). Neither 3CD deriva-
tive impaired induction of PIP2. Quantification of PIP2 intensity per cell (n = 30) was per-
formed as described in the legend to Fig 1C. The averages of the normalized values were:
1.03 ± 0.07 (SEM) in mock-transfected cells; 4.71 ± 0.27 (SEM) in 3CR13LD-transfected cells;
4.08 ± 0.27 (SEM) in 3CR84LD-transfected cells. The level of PIP2 induction observed in 3CD
mutant-transfected cells was not significantly different when compared to WT 3CD-trans-
fected cells based on a Student’s t-test. (D) The indicated 3CD derivatives were expressed indi-
vidually in HeLa cells and immunostained for the presence of PC (red) and 3CD (green). The
nucleus was stained with DAPI (blue). Neither 3CD derivative impaired induction of PC.
Quantification of PC intensity per cell (n = 20) was performed as described in the legend to
Fig 1C. The averages of the normalized values were: 1.00 ± 0.04 (SEM) in mock-transfected
cells; 2.52 ± 0.14 (SEM) in 3CR13LD-transfected cells; 2.02 ± 0.11 (SEM) in 3CR84LD-trans-
fected cells. The level of PC induction observed in 3CD mutant-transfected cells was not signif-
icantly different when compared to WT 3CD-transfected cells based on a Student’s t-test.
(PDF)
S1 Table. Oligonucleotides used in this study.
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S2 Table. Statistical analysis of all experimental data.
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